Atea pharmaceuticals inc.

Major-Pharmaceuticals

AVIR


125 Summer Street
Boston , MA 02110

Executive/
Director

Price

  • Last Close
  • $ 3.78
    $ -0.02 -0.66 %
    Aug 29, 2024
  • 52-Week High/Low
  • $4.56 - $2.8
  • YTD
  • 23.8%

  • Trading Volume
  • 9,652
  • Market Cap Full
  • $ 315.4M
  • Shares Outstanding
  • 83.4M
    Nov 7, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% 44.3% -19.5% -30.4% 32.5%
Q2 - - - - - 4% -63.6% -1.4% 11.6% -3.3%
Q3 - - - - - 8% 63.2% -19.9% -19.8% -
Q4 - - - - - 34.7% -74.5% -15.5% 1.7% -
J F M A M J J A S O N D
2024 36.4% 3.6% -6.3% -4.2% - - - - - - - -
2023 -3.7% -23.5% -5.4% -2.4% 22% -6.3% -8.3% -2% -10.7% 8.3% -8% 2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%-78%-46%-37%24%

Earnings

2019 2020 2021 2022 2023
Q1 - - 0.34 -0.51 -0.43
Q2 - - 0.02 -0.38 -0.34
Q3 - - -0.34 -0.1 -0.40
Q4 - - 1.35 -0.40 -
A -1.4 -0.5 1.4 -1.4 -1.17

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 82.7 83.2 83.3
Jun - 82.7 83.3 83.4
Sep - 82.8 83.3 83.4
Dec 82.6 83.1 83.3 83.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - 0.5 0.1 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 8.7 8.1 - 15 -
Equity multiplier - - - - -